Tetsu Watanabe

2.2k total citations
61 papers, 1.8k citations indexed

About

Tetsu Watanabe is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Tetsu Watanabe has authored 61 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 20 papers in Hepatology and 10 papers in Molecular Biology. Recurrent topics in Tetsu Watanabe's work include Liver Disease Diagnosis and Treatment (23 papers), Liver physiology and pathology (11 papers) and Hepatitis B Virus Studies (8 papers). Tetsu Watanabe is often cited by papers focused on Liver Disease Diagnosis and Treatment (23 papers), Liver physiology and pathology (11 papers) and Hepatitis B Virus Studies (8 papers). Tetsu Watanabe collaborates with scholars based in Japan, United States and Australia. Tetsu Watanabe's co-authors include Maki Niioka, Isao Okazaki, Hitoshi Endo, Mamoru Tanaka, Noriko Kobayashi, Yutaka Inagaki, Miwa Kushida, Katsuya Maruyama, Masaharu Tsuchiya and Toshio Morizane and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Tetsu Watanabe

56 papers receiving 1.7k citations

Peers

Tetsu Watanabe
O Gressner Germany
Wei Cai China
KyeongJin Kim South Korea
You-kyung Choi United States
Tetsu Watanabe
Citations per year, relative to Tetsu Watanabe Tetsu Watanabe (= 1×) peers Akihiro Moriuchi

Countries citing papers authored by Tetsu Watanabe

Since Specialization
Citations

This map shows the geographic impact of Tetsu Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsu Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsu Watanabe more than expected).

Fields of papers citing papers by Tetsu Watanabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsu Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsu Watanabe. The network helps show where Tetsu Watanabe may publish in the future.

Co-authorship network of co-authors of Tetsu Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsu Watanabe. A scholar is included among the top collaborators of Tetsu Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsu Watanabe. Tetsu Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Otaki, Yoichiro, Tetsu Watanabe, Junya Sato, et al.. (2025). Growth Differentiation Factor-15 and N-Terminal Pro-BNP in Acute Heart Failure with Preserved Ejection Fraction. ESC Heart Failure. 12(2). 888–899. 1 indexed citations
2.
Endo, Hitoshi, Tomoo Eto, Fumihito Yoshii, et al.. (2017). The intrauterine environment affects learning ability of Tokai high avoider rat offspring derived using cryopreservation and embryo transfer-mediated reproduction. Biochemical and Biophysical Research Communications. 489(2). 211–216. 3 indexed citations
3.
Netsu, Shunsuke, Yuki Honda, Tetsu Watanabe, et al.. (2014). Comorbidity of airflow limitation in patients with cardiovascular disease. 20(6). 3788–3800.
4.
Endo, Hitoshi, Maki Niioka, Noriko Kobayashi, Mamoru Tanaka, & Tetsu Watanabe. (2013). Butyrate-Producing Probiotics Reduce Nonalcoholic Fatty Liver Disease Progression in Rats: New Insight into the Probiotics for the Gut-Liver Axis. PLoS ONE. 8(5). e63388–e63388. 274 indexed citations
5.
Sakai, Takashi, N. Nakamura, Takashi Nishii, et al.. (2012). Histological characteristics of the human femoral head in patients with femoral neck fracture. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 461(6). 705–711.
6.
Jesmin, Subrina, Md. Reazul Islam, Sayeeda Sultana, et al.. (2012). Comprehensive assessment of metabolic syndrome among rural Bangladeshi women. BMC Public Health. 12(1). 49–49. 33 indexed citations
7.
Furuya, Hiroyuki, et al.. (2011). Female sexual dysfunction: Facts and factors among gynecology outpatients. Journal of obstetrics and gynaecology research. 38(1). 329–335. 14 indexed citations
8.
Kagawa, Tatehiro, Seiichiro Kojima, Shinji Takashimizu, et al.. (2007). Eight‐week oral administration of meloxicam, a non‐steroidal anti‐inflammatory drug, prevents dose reduction of pegylated interferon α‐2a in the treatment of chronic hepatitis C. Hepatology Research. 38(3). 259–266. 2 indexed citations
9.
Watanabe, Tetsu, Chisato Murata, & Yoshihisa Watanabe. (2005). Metabolic syndrome from the view point of public health: with special reference to nonalcoholic fatty liver disease.. PubMed. 52(11). 934–42. 7 indexed citations
10.
Sugioka, Yoshihiko, Tetsu Watanabe, Yutaka Inagaki, et al.. (2004). c‐jun NH2‐terminal kinase pathway is involved in constitutive matrix metalloproteinase‐1 expression in a hepatocellular carcinoma‐derived cell line. International Journal of Cancer. 109(6). 867–874. 32 indexed citations
11.
Inagaki, Yutaka, Tomoyuki Nemoto, Miwa Kushida, et al.. (2003). Interferon Alfa Down–Regulates Collagen Gene Transcription and Suppresses Experimental Hepatic Fibrosis in Mice. Hepatology. 38(4). 890–899. 104 indexed citations
12.
Watanabe, Tetsu, Maki Niioka, Akiko Ishikawa, et al.. (2001). Dynamic change of cells expressing MMP-2 mRNA and MT1-MMP mRNA in the recovery from liver fibrosis in the rat. Journal of Hepatology. 35(4). 465–473. 51 indexed citations
13.
Miyaguchi, Shingo, Hirotoshi Ebinuma, Hiroyuki Imaeda, et al.. (2001). A novel treatment for refractory primary biliary cirrhosis?. PubMed. 47(36). 1518–21. 32 indexed citations
14.
Okazaki, Isao, Tetsu Watanabe, Shigenari Hozawa, et al.. (2001). Reversibility of hepatic fibrosis: From the first report of collagenase in the liver to the possibility of gene therapy for recovery.. The Keio Journal of Medicine. 50(2). 58–65. 30 indexed citations
15.
Watanabe, Tetsu, Maki Niioka, Shigenari Hozawa, et al.. (2000). Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride. Journal of Hepatology. 33(2). 224–235. 92 indexed citations
16.
Hibi∥, Toshifumi, Masahiro Yoshioka, Kyoko Toda, et al.. (1993). Changes of Proliferative Activity and Phenotypes in Spontaneous Differentiation of a Colon Cancer Cell Line. Japanese Journal of Cancer Research. 84(6). 625–632. 32 indexed citations
17.
Saito, Hidetsugu, Toshio Morizane, Tetsu Watanabe, et al.. (1991). Proto-oncogene Expression in Three Human Hepatoma Cell Lines, HCC-M, HCC-T and PLC/PRF/5.. The Keio Journal of Medicine. 40(3). 139–145. 9 indexed citations
18.
Saito, Hidetsugu, Toshio Morizane, Tetsu Watanabe, et al.. (1990). Expression of hepatitis B surface antigen in chang cells transfected with hepatitis B virus DNA.. The Keio Journal of Medicine. 39(2). 79–85. 2 indexed citations
19.
Saito, Hidetsugu, Toshio Morizane, Tetsu Watanabe, et al.. (1989). Establishment of a human cell line (HCC-T) from a patient with hepatoma bearing no evidence of hepatitis B or A virus infection. Cancer. 64(5). 1054–1060. 37 indexed citations
20.
Morizane, Toshio, Naoki Kumagai, Hidetsugu Saito, et al.. (1986). New micro-glass-tube leukocyte adherence inhibition assay assessing cell adherence of mononuclear cell subpopulations defined by monoclonal antibodies. Journal of Immunological Methods. 91(2). 225–229. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026